|
Marché Fermé -
NYSE
22:00:02 04/11/2026
|
Après clôture 02:00:00 | |||
| 64,19 USD | +4,02% |
|
65,06 | +1,35% |
| 03/11 | Pfizer relève ses prévisions annuelles grâce à la forte demande | RE |
| 03/11 | Pfizer relève ses prévisions pour 2026, porté au troisième trimestre par Eliquis et ses médicaments contre le cancer | RE |
Univers
Place boursière
Europe
Amérique du Nord
Afrique
Asie
Océanie
Moyen-Orient
Amérique du Sud
Amérique centrale
Type
Maturité
Disponible seulement pour les produits à effet de levier
Levier / Elasticité
Produits Dérivés
| Mnemo | Type | Type de produit | Maturité | Elasticité | Levier | Parité | Cours | |||
|---|---|---|---|---|---|---|---|---|---|---|
CALL
| CALL | Obligations Convertibles | 19/02/2027 | - | 0.06 | 99.6 / 100.3 | ||||
CALL
| CALL | Certificat Turbo | Illimité | 2.66x | 5 | 4,335 EUR | ||||
CALL
| CALL | Obligations Convertibles | 01/03/2027 | - | 1 | 102.67 / 103.57 | ||||
CALL
| CALL | Obligations Convertibles | 01/03/2027 | - | 1 | 102.57 / 103.47 | ||||
CALL
| CALL | Obligations Convertibles | 08/03/2027 | - | 1 | 92.82 / 93.72 | ||||
CALL
| CALL | Warrants | 25/01/2027 | 10.83x | - | 5 | 0.32 / 0.33 | |||
CALL
| CALL | Certificat Turbo | Illimité | 3.41x | 5 | 3,395 EUR | ||||
PUT
| PUT | Warrants | 25/01/2027 | 10.45x | - | 5 | 0.08 / 0.09 | |||
CALL
| CALL | Certificats Discount | Illimité | - | 1 | 51.18 / 51.565 | ||||
CALL
| CALL | Certificats Discount | 26/01/2027 | - | 1 | 54.963 / 55.313 | ||||
PUT
| PUT | Warrants | 25/01/2027 | 9.93x | - | 5 | 0.16 / 0.17 | |||
PUT
| PUT | Warrants | 25/01/2027 | 8.57x | - | 5 | 0.36 / 0.37 | |||
CALL
| CALL | Obligations Convertibles | 02/03/2028 | - | 0.043 | 101.83 / 102.58 | ||||
CALL
| CALL | Obligations Convertibles | 02/03/2028 | - | 0.029 | 101.98 / 102.73 | ||||
CALL
| CALL | Certificat Turbo Stop Loss | Illimité | 2.31x | 10 | 2,456 EUR | ||||
CALL
| CALL | Certificat Turbo Stop Loss | Illimité | 3.32x | 10 | 1,710 EUR | ||||
PUT
| PUT | Warrants | 30/03/2027 | 6.64x | - | 5 | 0.32 / 0.33 | |||
PUT
| PUT | Warrants | 30/03/2027 | 5.73x | - | 5 | 0.6 / 0.61 | |||
CALL
| CALL | Warrants | 30/03/2027 | 6.98x | - | 5 | 0.61 / 0.62 | |||
CALL
| CALL | Warrants | 25/01/2027 | 8.73x | - | 5 | 0.62 / 0.63 | |||
CALL
| CALL | Warrants | 30/03/2027 | 6.08x | - | 5 | 0.94 / 0.95 | |||
CALL
| CALL | Certificat Turbo Stop Loss | Illimité | 5.4x | 20 | 0.5 / 0.51 | ||||
PUT
| PUT | Certificat Turbo Stop Loss | Illimité | 8.86x | 20 | 0.27 / 0.28 | ||||
CALL
| CALL | Certificat Turbo Stop Loss | Illimité | 4.93x | 25 | 0.43 / 0.44 | ||||
CALL
| CALL | Warrants | 28/01/2028 | 4.84x | - | 20 | 0.19 / 0.2 | |||
CALL
| CALL | Warrants | 28/01/2028 | 4.15x | - | 20 | 0.31 / 0.32 | |||
PUT
| PUT | Warrants | 28/01/2028 | 3.69x | - | 20 | 0.14 / 0.15 | |||
PUT
| PUT | Warrants | 30/03/2027 | 7.38x | - | 20 | 0.035 / 0.045 | |||
PUT
| PUT | Warrants | 25/01/2027 | 9.63x | - | 10 | 0.025 / 0.035 | |||
PUT
| PUT | Warrants | 25/01/2027 | 9.81x | - | 10 | 0.02 / 0.03 | |||
PUT
| PUT | Warrants | 28/01/2028 | 3.07x | - | 20 | 0.29 / 0.3 | |||
CALL
| CALL | Warrants | 28/01/2028 | 5.14x | - | 20 | 0.14 / 0.15 | |||
CALL
| CALL | Certificat Turbo | Illimité | 7.4x | 5 | 1,575 EUR | ||||
PUT
| PUT | Warrants | Illimité | - | 1 | 0.18 / 0.19 | ||||
PUT
| PUT | Certificat Turbo Stop Loss | Illimité | 5.3x | 25 | 0.37 / 0.38 | ||||
CALL
| CALL | Warrants | Illimité | - | 1 | 0.54 / 0.55 | ||||
CALL
| CALL | Certificat Turbo Stop Loss | Illimité | 3.47x | 25 | 0.61 / 0.62 | ||||
CALL
| CALL | Certificat Turbo Stop Loss | Illimité | 6.68x | 10 | 0.81 / 0.82 | ||||
RBMAKV 
4N89S - Bourse
- Actions
- Action BMY
- Dérivés Bristol-Myers Squibb Company
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
